SNBL animal models win anti-terror attack contract
CRO SNBL USA, daughter company of Shin Nippon, has won a BARDA contract for animal models to treat injuries from chemical, radiological and nuclear attack.
CRO SNBL USA, daughter company of Shin Nippon, has won a BARDA contract for animal models to treat injuries from chemical, radiological and nuclear attack.
Irish scientists have completed the most comprehensive structural study yet of a PEGylated protein, giving greater insight into how such molecules improve injectable therapies.
A team of researchers has modified a lectin protein found in bananas to diminish its inflammatory properties, potentially setting it on the path to use as an antiviral.
Covance has reported capacity use at its preclinical toxicology business is in the 70% range, meaning it is still well below optimal levels despite recent improvements.